DRAIC and prostate carcinoma: Accumulating evidence has reported that the differential expression of DRAIC in prostate cancer, lung cancer, glioma, breast cancer, colorectal cancer, esophageal cancer, gastric cancer, nasopharyngeal carcinoma, and retinoblastoma.